- An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low costBruce S Pyenson
Milliman, New York City, New York, USA
Health Aff (Millwood) 31:770-9. 2012..We also believe that payers and patients should demand screening from high-quality, low-cost providers, thus helping set an example of efficient system innovation...
- MAKING THE CASE FOR Biotechnology Reinsurance (BIO-RE)Bruce Pyenson
is a principal and a consulting actuary at Milliman Inc, in New York He can be reached by e mail at or by phone at 646 473 3201
Biotechnol Healthc 5:31-5. 2008..The author proposes a combined cost-management and care-delivery standard that could lessen that threat...